Mean over 2040–2060 of on-going vaccine effect, HIV incidence (per 1000 person years and death rate (/100 person years) in the whole population, according to variations in vaccine implementation characteristics.

Base scenario: Coverage 70%, boosting to age 50, with 80% completion rates to boosters, no tapering in effect over time, and with an adult catch-up program in 18–30 years covering 50% of the population of that age, rate vaccination  = 0.3/3mths, vaccine effect on VL in 100% of people, duration of vaccine effect 5 years, age of introduction 15. For each row, one characteristic is made different from the base scenario. 95% CI shown in Table S1, along with further comparisons.
Mean over 2040–2060 of on-going vaccine effect, HIV incidence (per 1000 person years and death rate (/100 person years) in the whole population, according to variations in vaccine implementation characteristics.